Empagliflozin impurity 207 CAS CATO-C4X-1065207

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-1065207
Molecular FormulaC15H15IO
Molecular Weight338.18 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Empagliflozin impurity 207 CAS CATO-C4X-1065207 chemical structure

Description

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

Empagliflozin impurity 207 (CAS CATO-C4X-1065207) is a certified pharmaceutical impurity reference standard with the molecular formula C15H15IO and a molecular weight of 338.18 g/mol.

Structurally, Empagliflozin impurity 207 (C15H15IO) contains a hydroxyl group, an ether linkage, iodine substitution, a polycyclic aromatic system. The molecule exhibits a degree of unsaturation (DBE) of 8.0, corresponding to approximately 8 ring(s) or double-bond equivalent(s). With a molecular weight of 338.18 g/mol, it falls into the moderately-high-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

As a certified reference material (CRM), Empagliflozin impurity 207 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC15H15IO
Molecular Weight338.18 g/mol
AppearancePale yellow to yellow crystalline powder. (slight halide-like odor)
Purity97%+
StorageStore at 2-8°C, protect from light
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate, DMSO
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)8.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
Halogen ContentI-containing

Related Empagliflozin Standards

Recommended Standards

Why CATO?